HappeningToo topic
Natalizumab reports
Browse community reports connected to Natalizumab. These reports can show that other people are describing similar experiences, but they do not prove that Natalizumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
38 problems
Abdominal Pain Upper while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and abdominal pain upper appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and alopecia appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and anxiety appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and back pain appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Burning Sensation while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and burning sensation appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and chills appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and constipation appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and cough appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and dehydration appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and diarrhea appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and dizziness appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and fatigue appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and feeling abnormal appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Flushing while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and flushing appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and headache appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and hives appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and hypotension appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Influenza Like Illness while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and influenza like illness appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and insomnia appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and itching appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and malaise appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and migraine appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and muscle spasms appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and muscular weakness appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and myalgia appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and nausea appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and pain appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and rash appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and shortness of breath appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and sleepiness appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and tingling or pins and needles appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and tremor appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vertigo while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and vertigo appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and vision blurred appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and vomiting appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and weakness appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and weight decreased appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Natalizumab
FDA FAERS contains adverse-event reports in which Natalizumab and weight increased appear together. This does not establish that Natalizumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →